Modeling Hepatitis C Elimination Among People Who Inject Drugs in New Hampshire.

ABSTRACT:

Importance

The success of direct-acting antiviral therapies for chronic hepatitis C virus (HCV) infection led the World Health Organization to set elimination targets by 2030. For the United States to achieve these benchmarks, public health responses must target high-risk populations, such as people who inject drugs (PWID), a group with high rates of HCV incidence and low rates of treatment uptake.

Objective

To evaluate potential improvements in the HCV care cascade among PWID, focusing on improved testing, treatment uptake, and access to harm reduction.

Design, setting, and participants

This decision analytic model used a differential equation-based dynamic transmission model based on data from New Hampshire, an illustrative state with a large number of PWID and limi

SUBMITTER: Blake A 

PROVIDER: S-EPMC8335578 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature